Discussion on the Monitoring of the Adverse Reaction and the Risk Management of Essential Medicines
LIU Cui-li, XIA Dong-sheng
Center for Drug Reevalutaion,CFDA, Beijing 100045, China)Abastract: Since the implementation of essential medicine system in China, the essential medicine adverse reaction monitoring work has made great achievements.It has been an important guarantee for the smooth implementation of the national essential medicine system. This paper starts from the practice of China's essential medicine monitoring work, analyzes the characteristics of the risk management of essential medicines, in order to cause the colleagues in depth discussion and research on this work, to ensure the safety of the public.
LIU Cui-li, XIA Dong-sheng. Discussion on the Monitoring of the Adverse Reaction and the Risk Management of Essential Medicines[J]. Chinese Journal of Pharmacovigilance, 2014, 11(10): 614-617.
